$967 Million is the total value of Invesco Private Capital's 12 reported holdings in Q2 2013. The portfolio turnover from Q1 2013 to Q2 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGO | New | Assured Guaranty Ltd. | $327,425,000 | – | 14,842,488 | +100.0% | 33.84% | – |
| XCO | New | Exco Resources Inc. | $240,691,000 | – | 31,504,077 | +100.0% | 24.88% | – |
| BKU | New | Bankunited Inc. | $213,012,000 | – | 8,189,631 | +100.0% | 22.02% | – |
| SNBC | New | Sun Bancorp Inc. | $72,137,000 | – | 21,279,241 | +100.0% | 7.46% | – |
| CACB | New | Cascade Bancorp | $71,221,000 | – | 11,468,750 | +100.0% | 7.36% | – |
| 2978PS | New | E2Open, Inc. | $23,650,000 | – | 1,351,450 | +100.0% | 2.44% | – |
| CALD | New | Callidus Software, Inc. | $9,631,000 | – | 1,461,406 | +100.0% | 1.00% | – |
| LPDX | New | LipoScience, Inc. | $5,062,000 | – | 724,213 | +100.0% | 0.52% | – |
| HLIT | New | Harmonic, Inc. | $3,295,000 | – | 518,846 | +100.0% | 0.34% | – |
| SEM | New | Select Medical | $944,000 | – | 115,121 | +100.0% | 0.10% | – |
| CYCC | New | Cyclacel Pharmaceuticals | $343,000 | – | 116,316 | +100.0% | 0.04% | – |
| ZIPR | New | ZipRealty | $38,000 | – | 12,282 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- WL Ross & Co. LLC #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NAVIGATOR HOLDINGS LTD. | 24 | Q3 2019 | 99.0% |
| Sun Bancorp Inc. | 19 | Q4 2017 | 35.4% |
| Exco Resources Inc. | 19 | Q4 2017 | 24.9% |
| XENON PHARMACEUTICALS, INC. | 18 | Q1 2019 | 1.0% |
| Cascade Bancorp | 16 | Q1 2017 | 20.3% |
| E2Open, Inc. Common Stock | 7 | Q4 2014 | 3.1% |
| Cyclacel Pharmaceuticals k | 7 | Q4 2014 | 0.1% |
| Talmer Bancorp Inc | 6 | Q2 2015 | 20.5% |
| LipoScience, Inc. Common Stock | 6 | Q3 2014 | 0.5% |
| Harmonic, Inc. Common Stock | 5 | Q2 2014 | 0.4% |
View Invesco Private Capital's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| E2open Inc | February 06, 2015 | 671,123 | 2.3% |
| CALLIDUS SOFTWARE INC | February 14, 2011 | 1,601,406 | 5.0% |
| MONTPELIER RE HOLDINGS LTDSold out | February 14, 2011 | 0 | 0.0% |
| Cyclacel Pharmaceuticals, Inc. | April 07, 2006 | 931,313 | - |
| SIGMATEL INC | February 11, 2005 | 447,881 | 1.3% |
| HEALTH GRADES INCSold out | March 12, 2003 | 0 | 0.0% |
| ALLOS THERAPEUTICS INC | October 02, 2002 | 861,961 | 3.8% |
| HEALTHGRADES COM INCSold out | March 23, 2001 | 0 | 0.0% |
| REPEATER TECHNOLOGIES INC | February 27, 2001 | 2,164,656 | 9.3% |
| TRANSGENOMIC INC | February 27, 2001 | 2,292,426 | 10.7% |
View Invesco Private Capital's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2019-12-05 |
| 4 | 2019-11-27 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 3 | 2019-04-08 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
View Invesco Private Capital's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.